On May 16, the American Academy of Dermatology will release appropriate use criteria for Mohs surgery. The document will be the first of its kind and "a home run for Mohs surgery," said Dr. Brett M. Coldiron, president of the American College of Mohs Surgery.
During the College's annual meeting in Chicago, Dr. Coldiron said that Mohs surgery is not being overutilized, contrary to what some may believe. The increase in utilization is, instead, the result of the nation's skin cancer epidemic, and the fact that Mohs surgery is effective both clinically and financially.
The College has retained a lobby firm in Washington, D.C. to raise Mohs surgery awareness, and is working with insurers on coverage.
In a video interview with Skin and Allergy News, Dr. Coldiron further explained the ACMS's position.